Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Vaccines|May 7, 2025
Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialYan Liu, Guangwei Feng, Jinyuan Wu, et al.
NPJ Vaccines|November 13, 2022
A potent, broadly protective vaccine against SARS-CoV-2 variants of concernZiyan Wang, Jiao An, Kunpeng Liu, et al.
Clinical and Translational Medicine|September 14, 2022
A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adultsDeyan Luo, Hongxing Pan, Peng He, et al.
Human Vaccines & Immunotherapeutics|July 1, 2017
Analysis of immunological mechanisms exerted by HBsAg-HBIG therapeutic vaccine combined with Adefovir in chronic hepatitis B patientsChenliang Zhou, Chaofan Li, Guo-Zhong Gong, et al.
The Lancet. Infectious Diseases|March 27, 2021
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trialsShilong Yang, Yan Li, Lianpan Dai, et al.
Expert Review of Vaccines|January 21, 2025
Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variantsGuiqiang Wang, Kexin Zhao, Xiuli Zhao, et al.
Vaccine|November 9, 2021
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvantsHaitao Liu, Chenliang Zhou, Jiao An, et al.
The New England Journal of Medicine|May 4, 2022
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in AdultsLianpan Dai, Lidong Gao, Lifeng Tao, et al.
Pageof 4